Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

2.76
Delayed Data
As of 3:59pm ET
 -0.21 / -7.07%
Today’s Change
1.50
Today|||52-Week Range
5.44
-10.10%
Year-to-Date

Today’s Trading

Previous close2.97
Today’s open2.97
Day’s range2.75 - 3.03
Volume963,901
Average volume (3 months)2,058,140
Market cap$284.7M
Dividend yield--
Data as of 3:59pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+23.39%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.85+7.07%
OXFDOxford Immunotec Glo...-0.13-1.24%
LNTHLantheus Holdings In...-0.22-2.98%
CLDXCelldex Therapeutics...-0.28-7.41%
Data as of 3:59pm ET, 08/24/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

Partner Offers

Search for Jobs